Condensed plasmid-liposome complex for transfection
AssigneeSequus Pharmaceuticals, Inc.
InventorsShi Kun Huang, Edwin Kiyoshi Oto, Mohammad Hassanipour, Bei Jin
Life of this patent
Estimating the term…
Abstract
An improvement in a method of preparing plasmid-liposome complexes for in vivo transfection is described. The improvement includes selecting a condensing agent to condense the plasmid prior to contact with the liposomes, selecting a working medium and selecting a ratio of liposome lipid to plasmid. Also disclosed are DNA plasmid-liposome complexes formed by the method.
Claims8
An improvement in a method of preparing plasmid-liposome complexes by condensing plasmid molecules and mixing the condensed plasmids with a suspension of cationic liposomes to form plasmid-liposome complexes for use in transfecting a host cell, said improvement comprising the steps of
- selecting as a condensing agent for condensing the plasmid molecules, a polycation selected from the group consisting of histones, poly-1-glutamine, melittin and polymyxin B,
- selecting as a medium for suspending said condensed plasmid molecules, a low-ionic strength aqueous medium, and
- selecting a ratio of liposome lipid to plasmid of greater than 10 nmole liposome lipid/.mu.g plasmid and less than 15 nmole liposome lipid/.mu.g plasmid,
- where the plasmid-liposome complexes produced by the improvement have:
- (i) sizes in the range of 120-180 nm and
- (ii) a transfection stability of at least 30 days, as evidenced by a stable in vivo transfection efficiency of the complex after storage for 30 days at 4.degree. C.
Dependencies are inferred from the claim text.